Recombinant Human Anti-FIXa x Human Anti-FX Bispecific Antibody (Tandem scFv-Fc) (BSFVF-H328)

Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv-Fc) is designed to be expressed as a homodimer, which has 2+2 antigen-binding valency. This format consists of one Fc region and two tandem scFv fragments, in which the anti-FIXa/FX tandem scFv is fused to the Fc domain. The engineered fragment format is used to extend the half-life. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.

Datasheet INQUIRY

Specifications

Targets

FIXa & FX

Type

Constant Domain-extended Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Hemophilia A

Targets

Target 1

FIXa

Gene ID

2158

UniProt ID

P00740

Alternative Names

F9; coagulation factor IX; FIX; P19; PTC; HEMB; THPH8; F9 p22; FIX F9; factor 9; factor IX F9; Christmas factor; plasma thromboplastic component; plasma thromboplastin component

Target 2

Gene ID

2159

UniProt ID

P00742

Alternative Names

F10; coagulation factor X; FX; FXA; factor Xa; prothrombinase; Stuart-Prower factor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-FIXa x Human Anti-FX Bispecific Antibody (Tandem scFv-Fc) (BSFVF-H328). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-FIXa x Human Anti-FX Bispecific Antibody (Tandem scFv-Fc) (CAT#: BSFVF-H328)

Specifications

Targets

Customer Reviews and Q&As